Alveron Pharma develops a drug, OKL-1111, to treat intracranial haemorrhage by reversing the effects of anticoagulants and platelet inhibitors.

RIFT develops iron fuel technology to provide a sustainable, CO2-free alternative for industrial heat in energy-intensive industries.